Literature DB >> 19222825

Effect of consistent condom use on 6-month prevalence of bacterial vaginosis varies by baseline BV status.

Marcel Yotebieng1, Abigail Norris Turner, Theresa Hatzell Hoke, Kathleen Van Damme, Justin Ranjalahy Rasolofomanana, Frieda Behets.   

Abstract

OBJECTIVES: Bacterial vaginosis (BV) is a condition characterized by a disturbed vaginal ecosystem which fluctuates in response to extrinsic and intrinsic factors. BV recurrence is common. To explore whether consistent condom use was associated with BV occurrence or recurrence, we compared the effect of condom use on BV prevalence after 6 months, among women with and without BV at baseline.
METHODS: We used data from a randomized controlled trial, conducted among female sex workers in Madagascar during 2000-2001, that assessed the impact of adding clinic-based counselling to peer education on sexual risk behaviour and sexually transmitted infection incidence. BV was diagnosed at two time points (baseline and 6 months) according to modified Amsel criteria. Consistent condom users were women reporting no unprotected sex acts with clients in the past month or non-paying partners in the past year. Adjusted prevalence ratios (PRs) and 95% confidence intervals (CIs) were calculated using multivariable regression models.
RESULTS: At baseline, 563 (56%) women had BV. Of those, 360 (72%) had BV at 6 months, compared to 158 (39%) without BV at baseline. The adjusted 6-month PR for BV comparing consistent to inconsistent condom users was 0.99 (95% CI: 0.85-1.13) among women with BV at baseline and 0.57 (95% CI: 0.30-0.94) among women without BV at baseline.
CONCLUSIONS: Consistent condom use was associated with reduced BV prevalence at 6 months for women who were BV-negative at baseline, but had no effect among women who were BV-positive at baseline. Male condoms appeared to protect against BV occurrence, but not BV recurrence.

Entities:  

Mesh:

Year:  2009        PMID: 19222825      PMCID: PMC5161033          DOI: 10.1111/j.1365-3156.2009.02235.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  25 in total

1.  Results of a randomised trial of male condom promotion among Madagascar sex workers.

Authors:  P J Feldblum; T Hatzell; K Van Damme; M Nasution; A Rasamindrakotroka; T W Grey
Journal:  Sex Transm Infect       Date:  2005-04       Impact factor: 3.519

2.  Clinical characteristics of vaginal discharge in bacterial vaginosis diagnosed by Nugent's criteria.

Authors:  E D Hapsari; M Hayashi; H Matsuo
Journal:  Clin Exp Obstet Gynecol       Date:  2006       Impact factor: 0.146

3.  Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression.

Authors:  A Russell Localio; David J Margolis; Jesse A Berlin
Journal:  J Clin Epidemiol       Date:  2007-01-18       Impact factor: 6.437

4.  Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis.

Authors:  Catriona Susan Bradshaw; Anna N Morton; Suzanne M Garland; Margaret B Morris; Lorna M Moss; Christopher K Fairley
Journal:  Obstet Gynecol       Date:  2005-07       Impact factor: 7.661

5.  Socio-demographic and behavioural factors associated with high incidence of sexually transmitted infections in female sex workers in Madagascar following presumptive therapy.

Authors:  Frieda M-T Behets; Kathleen Van Damme; Andry Rasamindrakotroka; Marcia Hobbs; Kristi McClamroch; Justin Ranjalahy Rasolofomanana; Leonardine Raharimalala; Gina Dallabetta; Jocelyne Andriamiadana
Journal:  Sex Health       Date:  2005       Impact factor: 2.706

6.  Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina.

Authors:  Roberta B Ness; Sharon L Hillier; Holly E Richter; David E Soper; Carol Stamm; James McGregor; Debra C Bass; Richard L Sweet; Peter Rice
Journal:  Obstet Gynecol       Date:  2002-10       Impact factor: 7.661

7.  Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection.

Authors:  Harold C Wiesenfeld; Sharon L Hillier; Marijane A Krohn; Daniel V Landers; Richard L Sweet
Journal:  Clin Infect Dis       Date:  2003-02-07       Impact factor: 9.079

8.  High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.

Authors:  Catriona S Bradshaw; Anna N Morton; Jane Hocking; Suzanne M Garland; Margaret B Morris; Lorna M Moss; Leonie B Horvath; Irene Kuzevska; Christopher K Fairley
Journal:  J Infect Dis       Date:  2006-04-26       Impact factor: 5.226

9.  Randomised controlled trial of alternative male and female condom promotion strategies targeting sex workers in Madagascar.

Authors:  Theresa H Hoke; Paul J Feldblum; Kathleen Van Damme; Marlina D Nasution; Thomas W Grey; Emelita L Wong; Louisette Ralimamonjy; Leonardine Raharimalala; Andry Rasamindrakotroka
Journal:  Sex Transm Infect       Date:  2007-06-25       Impact factor: 3.519

10.  A randomized double-blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis.

Authors:  T Vutyavanich; P Pongsuthirak; P Vannareumol; R A Ruangsri; P Luangsook
Journal:  Obstet Gynecol       Date:  1993-10       Impact factor: 7.661

View more
  9 in total

1.  Factors Associated With Incidence and Spontaneous Clearance of Molecular-Bacterial Vaginosis: Results From a Longitudinal Frequent-Sampling Observational Study.

Authors:  Jeanne Tamarelle; Michelle D Shardell; Jacques Ravel; Rebecca M Brotman
Journal:  Sex Transm Dis       Date:  2022-06-21       Impact factor: 3.868

Review 2.  Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses.

Authors:  Christina A Muzny; Jane R Schwebke
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

3.  Serum vitamin D status and bacterial vaginosis prevalence and incidence in Zimbabwean women.

Authors:  Abigail N Turner; Patricia Carr Reese; Pai Lien Chen; Cynthia Kwok; Rebecca D Jackson; Mark A Klebanoff; Raina N Fichorova; Tsungai Chipato; Charles S Morrison
Journal:  Am J Obstet Gynecol       Date:  2016-03-02       Impact factor: 8.661

4.  Behavioural and medical predictors of bacterial vaginosis recurrence among female sex workers: longitudinal analysis from a randomized controlled trial.

Authors:  Fernand A Guédou; Lut Van Damme; Jennifer Deese; Tania Crucitti; Marissa Becker; Florence Mirembe; Suniti Solomon; Michel Alary
Journal:  BMC Infect Dis       Date:  2013-05-08       Impact factor: 3.090

5.  Antibacterial treatment of bacterial vaginosis: current and emerging therapies.

Authors:  Jean-Pierre Menard
Journal:  Int J Womens Health       Date:  2011-08-23

6.  The epidemiology of bacterial vaginosis in relation to sexual behaviour.

Authors:  Hans Verstraelen; Rita Verhelst; Mario Vaneechoutte; Marleen Temmerman
Journal:  BMC Infect Dis       Date:  2010-03-30       Impact factor: 3.090

7.  Association between semen exposure and incident bacterial vaginosis.

Authors:  Maria F Gallo; Lee Warner; Caroline C King; Jack D Sobel; Robert S Klein; Susan Cu-Uvin; Anne M Rompalo; Denise J Jamieson
Journal:  Infect Dis Obstet Gynecol       Date:  2011-12-08

Review 8.  Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis.

Authors:  Lenka A Vodstrcil; Jane S Hocking; Matthew Law; Sandra Walker; Sepehr N Tabrizi; Christopher K Fairley; Catriona S Bradshaw
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

Review 9.  Community empowerment and involvement of female sex workers in targeted sexual and reproductive health interventions in Africa: a systematic review.

Authors:  Lizzie Moore; Matthew F Chersich; Richard Steen; Sushena Reza-Paul; Ashar Dhana; Bea Vuylsteke; Yves Lafort; Fiona Scorgie
Journal:  Global Health       Date:  2014-06-10       Impact factor: 4.185

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.